Healios AG

company

About

Healios AG is a MedTech company aiming to develop and validate digital biomarkers

  • Basel,Basel-Stadt,Switzerland
  • 11 - 50

Details

Last Funding Type
Seed
Industries
Clinical Trials,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Healios AG
Also Known As
Healios

Healios is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies. With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders. These novel biomarkers will establish a new standard for both pharmacological research and clinical practice.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
Fr3.84M $174.68K
Healios AG has raised a total of Fr3.84M $174.68K in funding over 2 rounds. Their latest funding was raised on Aug 30, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 30, 2022 Seed 2 Detail
Dec 21, 2021 Angel Fr1.10M Detail
Aug 4, 2020 Grant $174.68K Detail
Jul 6, 2020 Convertable Note Fr1.10M Detail
Oct 10, 2019 Grant Fr55K Detail

Investors

Number of Lead Investors
Number of Investors
2
Healios AG is funded by 2 investors. Lichtsteiner Foundation and Zühlke Ventures AG are the most recent investors.
Investor Name Lead Investor Funding Round
Lichtsteiner Foundation Seed
Zühlke Ventures AG Seed

Employee Profiles

Number of Employee Profiles
6
Healios AG has 6 current employee profiles, including Executive Corne de Jong
Executive
Executive
Executive
Board member
Board member